Spooren WP[au] - Search Results

Year	Number of Results
1989	1
1991	3
1993	2
1995	2
1996	1
1998	2
1999	2
2000	6
2001	1
2002	1
2003	1
2004	1
2005	1
2023	0

1

Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.

Spooren WP, Gasparini F, Salt TE, Kuhn R. Spooren WP, et al. Trends Pharmacol Sci. 2001 Jul;22(7):331-7. doi: 10.1016/s0165-6147(00)01694-1. Trends Pharmacol Sci. 2001. PMID: 11431019 Review.

2

Neuropathology in mice expressing human alpha-synuclein.

van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G. van der Putten H, et al. Among authors: spooren wp. J Neurosci. 2000 Aug 15;20(16):6021-9. doi: 10.1523/JNEUROSCI.20-16-06021.2000. J Neurosci. 2000. PMID: 10934251 Free PMC article.

3

Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion.

Bills C, Schachtman TR, Serfozo P, Spooren WP, Gasparini F, Simonyi A. Bills C, et al. Among authors: spooren wp. Behav Brain Res. 2005 Feb 10;157(1):71-8. doi: 10.1016/j.bbr.2004.06.011. Behav Brain Res. 2005. PMID: 15617773

4

CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.

Waldmeier PC, Spooren WP, Hengerer B. Waldmeier PC, et al. Among authors: spooren wp. Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):526-37. doi: 10.1007/s002100000300. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 11138845

5

Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.

Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C. Spooren WP, et al. J Pharmacol Exp Ther. 2000 Dec;295(3):1267-75. J Pharmacol Exp Ther. 2000. PMID: 11082464

6

Efferent connections of the striatopallidal and amygdaloid components of the substantia innominata in the cat: projections to the nucleus accumbens and caudate nucleus.

Spooren WP, Veening JG, Groenewegen HJ, Cools AR. Spooren WP, et al. Neuroscience. 1991;44(2):431-47. doi: 10.1016/0306-4522(91)90067-x. Neuroscience. 1991. PMID: 1944894

7

Subregions of the caudate nucleus and their in- and output channels in oro-facial dyskinesia: a behavioural and retrograde tracing study in the cat.

Spooren WP, Groenewegen HJ, Cools AR. Spooren WP, et al. Brain Res. 1991 Jan 18;539(1):85-93. doi: 10.1016/0006-8993(91)90689-s. Brain Res. 1991. PMID: 1707740

8

The substantia innominata complex and the peripeduncular nucleus in orofacial dyskinesia: a pharmacological and anatomical study in cats.

Spooren WP, Mulders WH, Veening JG, Cools AR. Spooren WP, et al. Neuroscience. 1993 Jan;52(1):17-25. doi: 10.1016/0306-4522(93)90177-h. Neuroscience. 1993. PMID: 8433805

9

Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.

Spooren WP, Gasparini F, van der Putten H, Koller M, Nakanishi S, Kuhn R. Spooren WP, et al. Eur J Pharmacol. 2000 May 26;397(1):R1-2. doi: 10.1016/s0014-2999(00)00269-7. Eur J Pharmacol. 2000. PMID: 10844118

10

Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.

Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, Spooren WP. Cryan JF, et al. Among authors: spooren wp. J Pharmacol Exp Ther. 2004 Sep;310(3):952-63. doi: 10.1124/jpet.104.066753. Epub 2004 Apr 27. J Pharmacol Exp Ther. 2004. PMID: 15113848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results